Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavo

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|February 3, 2015
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantationA Brioli, G Perrone, F Patriarca, et al.
Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.
Annals of Hematology|March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective studyF Palandri, G Auteri, E Abruzzese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia|June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinibF Castagnetti, G Gugliotta, M Breccia, et al.
Clinical and Experimental Medicine|November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomideI Rizzello, I Sacchetti, S Barbato, et al.
British Journal of Haematology|May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centresG Gahrton, H Svensson, M Cavo, et al.
Cancer Medicine|November 26, 2024
Clinical Presentation and Long-Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective StudyK Mancuso, R Mina, S Rocchi, et al.
Leukemia|October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active diseaseE Zamagni, C Nanni, F Gay, et al.
Leukemia|July 21, 2006
International uniform response criteria for multiple myelomaB G M Durie, J-L Harousseau, J S Miguel, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|February 3, 2015
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantationA Brioli, G Perrone, F Patriarca, et al.
Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.
Annals of Hematology|March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective studyF Palandri, G Auteri, E Abruzzese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia|June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinibF Castagnetti, G Gugliotta, M Breccia, et al.
Clinical and Experimental Medicine|November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomideI Rizzello, I Sacchetti, S Barbato, et al.
British Journal of Haematology|May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centresG Gahrton, H Svensson, M Cavo, et al.
Cancer Medicine|November 26, 2024
Clinical Presentation and Long-Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective StudyK Mancuso, R Mina, S Rocchi, et al.
Leukemia|October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active diseaseE Zamagni, C Nanni, F Gay, et al.
Leukemia|July 21, 2006
International uniform response criteria for multiple myelomaB G M Durie, J-L Harousseau, J S Miguel, et al.
Pageof 15